Trial Profile
Postoperative analgesia in major ortopedic surgery: continuos epidural perfusion with laevobupivacaine 0.125% vs continuos epidural perfusion with laevobupivacaine 0.125% + sufentanil 0.5 gamma/ml.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 08 May 2020
Price :
$35
*
At a glance
- Drugs Sufentanil (Primary) ; Levobupivacaine
- Indications Postoperative pain
- Focus Therapeutic Use
- Acronyms PROTESI
- 08 May 2020 Status changed from completed to discontinued.
- 13 Aug 2011 New trial record